Jürgen Eck and Lukas Linnig, BRAIN’s CEO and Head of Investor Relations, respectively. This initial leg of the research was accelerated by a meeting at Bloomberg’s Frankfurt office with Dr. It took the team just over a month to educate ourselves on the basic science driving the biotechnology industry and grasp a clear picture of BRAIN’s business model. As an industrial, or “white,” biotechnology company, BRAIN operates in a niche industry, focusing on only pure biotechnology across three main technological platforms: enzymes, microorganisms, and bioactive compounds.
On the introductory call, the CFA Society Germany stressed that this was a unique company to value, and they certainly were not exaggerating. Recognizing that we had high expectations following the strong performances of previous Frankfurt School teams, we set out right away to conduct research and build the analysis on BRAIN.
Rok Cerin, Joming Chiang, Johannes Kirchmayr, Luccas Nepomuceno, and I were among those selected to participate in what would be our biggest professional feat to date.ĭuring an introductory phone call with the CFA Society Germany in October, all teams competing in the German competition learned their target company would be Biotechnology Research and Information Network AG, commonly referred to as BRAIN AG. In October, Frankfurt School nominated five Master of Finance students to represent the university in the CFA Institute Research Challenge, a global equity research competition designed to foster the corporate valuation and financial analysis skills of aspiring investment professionals.
0 kommentar(er)
